MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC)

by on 24 de gener de 2022 with No hi ha comentaris
  • Alsina, M., Ponz-Sarvise, M., Garcia, D. L., Gonzalez, M., De Andrea, C. E., Gros, A., . . . Tabernero, J., … Melero, I. (2021). MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC). Journal of Clinical Oncology, 39(15). https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS4155 (Meeting abstract)

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *